Board of Directors – Curasight

Skip to content

About Us
Technology
Pipeline
- Programmes
News & Events
- News
- Conferences
Contact
Search for:

Search for:

Home / About Us / Board of Directors

Management Team
Board of Directors
History

Mr. Lars Trolle
Chairman & Co-owner

Mr. Ulrich Krasilnikoff
CEO & Co-owner

Professor Andreas Kjaer
CSO & Co-founder

Curasight is a pioneer in the field of exploiting a novel PET imaging target – the urokinase-type plasminogen activator receptor (uPAR) – for improved prostate cancer diagnose.

Latest News

30
Oct

October 30, 2019 Comments Off on October 30, 2019
22
May

May 22, 2018 Comments Off on May 22, 2018
01
Mar

March 1, 2018 Comments Off on March 1, 2018

Tags

68Ga-NOTA-AE105 Academia Cancer Clinical Development Nuclear Patent PET Prostate cancer Studies surgery Treatment uPAR uTRACE

Newsletter

Sign up our newsletter and get the latest news first.

Copyright 2020 © Curasight

News & Events
Contact

Search for:
About Us
Technology
Pipeline
- Programmes
News & Events
- News
- Conferences
Contact
Login

Login

Username or email address *

Password *

Remember me

Lost your password?